- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Adenocarcinoma, Clear Cell
Medical specialists from France tagged as investigators in clinical trials studying Adenocarcinoma, Clear Cell
Total 12 results
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child
-
Cyril AbdeddaimSeen in:
- Lille, Centre Oscar Lambret
- Lille, Oscar Lambret Center
- Nord, Lille, Site 3602 - Centre Oscar Lambret
Trials:- NCT03088059 (Principal Investigator)
- NCT05128825 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Carcinoma, Squamous Cell of Head and Neck;
- High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
-
François GERNIERSeen in:
- Caen, Centre François Baclesse
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Guillaume BONNETSeen in:
- Amiens, CHU Amiens
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Laurence ROTSAERTSeen in:
- Lille, Centre Oscar Lambret
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Lauriane EberstSeen in:
- Strasbourg, Strasbourg Europe Institut of Cancerology
Trials:- NCT04104776 (Principal Investigator)
-
Mathieu BOONE, MDSeen in:
- Amiens, CHU Amiens
Trials:- NCT05500391 (Sub-Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Mehdi BrahmiSeen in:
- Lyon, Centre Léon Bérard
- Lyon, Léon Bérard Center
- Rhone, Lyon cedex 08, Centre Léon Bérard
Trials:- NCT04104776 (Principal Investigator)
- NCT04927260 (Principal Investigator)
- NCT04936178 (Principal Investigator)
-
Nicolas PENEL, MDSeen in:
- Lille, Centre Oscar Lambret
Trials:- NCT05500391 (Sub-Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Thomas GastinneSeen in:
- Loire-Atlantique, Nantes, CHU de Nantes - Hematologie
- Loire-Atlantique, Nantes, CHU de Nantes - Service d'Hématologie Clinique Place Alexis Ricordeau
- Loire-Atlantique, Nantes, Service d'Hématologie Clinique Place Alexis Ricordeau
- Nantes Cedex 1, Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
- Nantes, CHU Nantes
- Nantes, Hospital North
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital (Satellite)
- Other, Nantes cedex 1, Centre Hospitalier Universitaire Nantes-Hotel Dieu
Trials:- NCT04662255 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT04224493 (Principal Investigator)
- NCT04446962 (Principal Investigator)
Conditions:- Lymphoma, Mantle-Cell;
- Diffuse Large B-cell Lymphoma;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Follicular Lymphoma;
- Relapsed/Refractory Follicular Lymphoma;
- Refractory Follicular Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary
-
Vincent Ribrag, MDSeen in:
- Val De Marne, Villejuif cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05176691 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
Clinical Trials on Adenocarcinoma, Clear Cell
-
M.D. Anderson Cancer CenterRecruitingHuman Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-TypeUnited States
-
National University Hospital, SingaporeUnknownOvarian Clear Cell CarcinomaSingapore
-
M.D. Anderson Cancer CenterGSK Pharma; LixteRecruitingOvarian Clear Cell CarcinomaUnited States
-
Peking University Third HospitalNot yet recruitingOvarian Clear Cell Carcinoma
-
University Health Network, TorontoCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedStage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial AdenocarcinomaUnited States
-
Tongji HospitalWuhan University; Henan Cancer Hospital; Qilu Hospital of Shandong University; Hubei... and other collaboratorsRecruitingOvarian Clear Cell CarcinomaChina
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary Peritoneal Carcinoma | Recurrent Primary Peritoneal...United States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell AdenocarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States